Table 1.

Drugs used in this study

Drug name	Mechanism of action
Cladribine	Ribonucleotide reductase inhibitor
Fludarabine	Ribonucleotide reductase inhibitor
Gemcitabine	Ribonucleotide reductase inhibitor
Azacitidine	Ribonucleotide reductase inhibitor
Cytarabine	Ribonucleotide reductase inhibitor
5-fluorouracil	Thymidylate synthase inhibitor
Floxuridine	Thymidylate synthase inhibitor
Epirubicin	DNA intercalators and topoisomerase 2 inhibitors
Doxorubicin	DNA intercalators and topoisomerase 2 inhibitors
Daunorubicin	DNA intercalators and topoisomerase 2 inhibitors
Idarubicin	DNA intercalators and topoisomerase 2 inhibitors
Mitoxantrone	DNA intercalators and topoisomerase 2 inhibitors
Vincristine	Microtubule destabilizers
Vinorelbine	Microtubule destabilizers
Vinblastine	Microtubule destabilizers
Docetaxel	Microtubule stabilizers
Paclitaxel	Microtubule stabilizers
Oxaliplatin	DNA crosslinkers
Carboplatin	DNA crosslinkers
Etoposide	Topoisomerase 2 inhibitors
Teniposide	Topoisomerase 2 inhibitors
Arsenic trioxide	Other
Bleomycin	Other
Busulfan	Other
Hydroxyurea	Other
Mitomycin	Other
Rapamycin	Other
Temozolomide	Other
Topotecan	Other